This site is intended for health professionals only
Sunday 17 December 2017
Share |

Topic: Patient care

September 22, 2017
Four new wristband lines have been launched to complement SATO Europe’s premium Thermal Transfer Line wristband, which has proved popular with both patients and hospital staff

SATO Europe, a global leader in the development of Auto-Identification and labelling solutions, has unveiled a new range of pioneering ID wristbands for the healthcare sector to enhance patient safety, security and comfort.
 
The new range includes the Direct Thermal (DT) Line, Eco Line, Laser Line and RFID Line.
 

September 12, 2016
New report shows at least a fifth of the National Health Service providers’ deficit in 2016- 2017 could be saved if every acute trust implemented clinical care in the home

Increasing the use of clinical care in the home could save the NHS money, enable acute trusts to carry out more elective surgery, and manage more emergency admissions, a new report shows.

The report, There’s no place like home, shows the NHS in England could save a potential 500,000 bed days every year if every acute trust used virtual wards at the same scale as the trusts studied for the report. This could save at least £120 million, or 21% of all NHS providers’ predicted deficit for 2016-2017.1

May 25, 2016
New technology makes incident reporting easy and efficient

Imperial College Healthcare NHS Trust, a provider of acute and specialist health services with 10,000 staff is using Datix software to increase efficiencies within the Trust. Since implementing the latest web-based Datix incident, risk, legal and safety alerts modules, the Trust has increased incident reporting levels which in turn has helped the Trust respond more efficiently to risks, as well as ensuring team learning from incidents.
 

May 17, 2016
A1M Pharma has initiated a research collaboration with global biotherapeutics company CSL Behring to investigate the potential of combining Alpha 1 Microglobulin (A1M) with proteins extracted from the fractionation of human plasma such as hemopexin and haptoglobin

A1M Pharma has initiated a research collaboration with global biotherapeutics company CSL Behring to investigate the potential of combining Alpha 1 Microglobulin (A1M) with proteins extracted from the fractionation of human plasma such as hemopexin and haptoglobin. This collaboration strengthens A1M Pharma’s position in the use of A1M for the treatment of life-threatening diseases with therapies that are based on naturally occurring substances.
 

May 13, 2016
First Fc Fusion therapy approved for haemophilia B in the EU to provide extended protection against bleeds

Swedish Orphan Biovitrum AB (publ) (Sobi™) and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy, for the treatment of haemophilia B in all 28 European Union (EU) Member States and maintained its orphan designation. Alprolix is the only recombinant factor IX Fc Fusion protein therapy for haemophilia B to offer people in the EU prolonged protection against bleeding episodes with fewer prophylactic injections.

May 5, 2016
New integrated surgical theatres built to improve patient care. State of the art surgical imaging and tissue management technologies installed. Improved hospital efficiencies as part of NHS Five Year Forward View

Olympus Medical is proud to announce their partnership with one of London’s largest and busiest teaching hospitals King’s College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency. Through the partnership two new operating theatres have been created featuring upgraded surgical technologies including Full HD (FHD), 3D and 4K surgical imaging platforms and surgical tissue management system ‘THUNDERBEAT’.

May 5, 2016
New integrated surgical theatres built to improve patient care. State of the art surgical imaging and tissue management technologies installed. Improved hospital efficiencies as part of NHS Five Year Forward View

Olympus Medical is proud to announce their partnership with one of London’s largest and busiest teaching hospitals King’s College Hospital (KCH), with the aim of improving patient care, as well as overall efficiency. Through the partnership two new operating theatres have been created featuring upgraded surgical technologies including Full HD (FHD), 3D and 4K surgical imaging platforms and surgical tissue management system ‘THUNDERBEAT’.

April 20, 2016
EADV launched a Global Call to Action urging policy-makers, employers, workers’ organisations and physicians to protect Europe’s outdoor workers from skin cancer caused by solar UV-radiation

The European Academy of Dermatology and Venereology (EADV) launched a Global Call to Action urging policy-makers, employers, workers’ organisations and physicians to protect Europe’s outdoor workers from skin cancer caused by solar UV-radiation. The Call was launched at a policy debate in the European Parliament, hosted by MEP Nessa Childers (S&D), Vice President of the European Parliamentary Interest Group ‘MEPs Against Cancer’, and co-hosted by MEPs Mr Ole Christensen (S&D) and Mr Jens Gieseke (EPP).

April 20, 2016
Real-world data also demonstrate positive experience with TECFIDERA

Biogen present new TECFIDERA (dimethyl fumarate) research at the 68th annual meeting of the American Academy of Neurology (AAN) in Vancouver, Canada. The data presented supports the value of dimethyl fumarate in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS), and provides additional information supporting the efficacy and safety profile, as well as real-world patient-reported outcomes.1,2,3,4
 
More than half of patients free from disease activity over six years

April 14, 2016
Swedish Orphan Biovitrum AB and collaboration partner Biogen have received a positive opinion from the Committee for Orphan Medicinal Products of the European Medicines Agency recommending the European Commission to maintain the orphan designation for Alprolix®, a recombinant factor IX Fc fusion protein therapy for the treatment of haemophilia B

April 14, 2016
New first-in-class inhaled antibiotic for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adults with Cystic Fibrosis now available in Germany and Denmark

Raptor Pharmaceuticals Corp. announced that Quinsair (levofloxacin nebulizer solution) is now available in Germany and Denmark. Quinsair is the first inhaled fluoroquinolone approved in the European Union for the management of chronic pulmonary infections due to P. aeruginosa in adults with cystic fibrosis (CF).1,2 The product is administered twice-daily, stored at room temperature and has a short administration time.

April 6, 2016
Novel liquid biopsy RAS testing now available to clinical practices for metastatic colorectal cancer (mCRC) patients. The test will help guide physicians to select the most effective treatment for mCRC patients in a timely manner

April 4, 2016
New data presented at the American College of Cardiology shows that patients who develop stress-induced ischaemia (inadequate oxygen flow to the heart) have higher levels of troponin, which are associated with worse long term outcomes.

New data presented at the American College of Cardiology shows that patients who develop stress-induced ischaemia (inadequate oxygen flow to the heart) have higher levels of troponin,1  which are associated with worse long term outcomes.2

Doctors could eventually use this information to prevent serious complications from developing by helping patients manage stress through treatment and therapies.
 

April 4, 2016
First-in-class monoclonal antibody targeting CD38 for the treatment of multiple myeloma

April 4, 2016
If approved, TREVICTA® will be the first treatment for schizophrenia to be administered four times a year and will provide the longest dosing interval available for an antipsychotic medication in the European Union

April 1, 2016
Clinicians will soon have access to patient’s complete medical record for the first time

InterSystems, a global leader in health information technology, today announced a partnership with Lincolnshire Health and Care (LHAC) that will help LHAC achieve its ambitious goal to transform health and social care services in the county, potentially saving up to £4 million every year.

April 1, 2016
Clinicians will soon have access to patient’s complete medical record for the first time

InterSystems, a global leader in health information technology, today announced a partnership with Lincolnshire Health and Care (LHAC) that will help LHAC achieve its ambitious goal to transform health and social care services in the county, potentially saving up to £4 million every year.

March 31, 2016
First-ever treatment for rare bleeding disorder ‘hereditary factor X deficiency’ approved in Europe

Bio Products Laboratory, Limited (BPL) announced that the European Medicines Agency has granted marketing authorisation for Coagadex. Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency. Coagadex is the first and only treatment licensed specifically for this rare bleeding disorder in Europe.1

March 31, 2016
ESCMID is an organisation that explores risks, knowledge sharing and best practices in the fight against infectious disease

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organisation that explores risks, knowledge sharing and best practices in the fight against infectious disease – has received more than 300 late-breaker abstract submissions for its annual congress, ECCMID 2016 in Amsterdam.
 

March 23, 2016
An innovative North East healthcare project is helping to improve patient safety in hospitals, making sure patients feel that they are ‘in the loop’ when it comes to their care

ThinkSAFE is a new free-to-use service providing support to patients and their families to work with clinicians and healthcare professionals to improve the safety of patients in hospital. Originally developed as part of a programme of research funded by the National Institute of Health Research, and set up thanks to £110,000 funding from the Academic Health Science Network North East and North Cumbria (AHSN NENC), the service has already generated national interest from the Department of Health and recently won a Patient Experience Network national award.

March 23, 2016
An innovative North East healthcare project is helping to improve patient safety in hospitals, making sure patients feel that they are ‘in the loop’ when it comes to their care

ThinkSAFE is a new free-to-use service providing support to patients and their families to work with clinicians and healthcare professionals to improve the safety of patients in hospital. Originally developed as part of a programme of research funded by the National Institute of Health Research, and set up thanks to £110,000 funding from the Academic Health Science Network North East and North Cumbria (AHSN NENC), the service has already generated national interest from the Department of Health and recently won a Patient Experience Network national award.

March 22, 2016
Ten independent studies validate the growing bank of real-life clinical evidence to support switching patients from the reference infliximab (Remicade®) to biosimilar infliximab

March 21, 2016
Over two-thirds of patients with moderate to severe ulcerative colitis experienced clinical response after SIMPONI® induction. Study also shows significant improvement in disease-specific and generic quality of life in patients

MSD (known as Merck & Co., Inc., Kenilworth, NJ, USA in the United States and Canada) announced new findings presented at the 11th Congress of the European Crohn’s and Colitis Organisation (ECCO) from GO-COLITIS, a UK study evaluating the efficacy of golimumab (GLM) in inducing and maintaining clinical response in 205 anti-TNF naïve patients with moderate to severe UC.

March 21, 2016
Last month, St George’s Hospital – one of the biggest in the UK – opened their new hi-tech Hybrid Operating Theatre, where state of the art imaging could mean less invasive surgery and safer procedures for patients

Last month, St George’s Hospital – one of the biggest in the UK – opened their new hi-tech Hybrid Operating Theatre, where state of the art imaging could mean less invasive surgery and safer procedures for patients.